Media

Press Releases and Events

Angelini Pharma acquires Arvelle Therapeutics to create a leading European innovator in Central Nervous System (CNS) and Mental Health Disorder treatments

Arvelle Announces Partnership with Durbin Across Europe

Cenobamate Designated Promising Innovative Medicine (PIM) by the UK’s MHRA for Treatment of Drug-Resistant Focal-Onset Seizures in Adults

Jefferies 2020 London Healthcare Conference

Close
    1. Cross JH. Epilepsia. 2011;52(1):187–188.
    2. Chen Z, et al. JAMA Neurol. 2018;75(3):279–286.
    3. Kwan P and Brodie MJ. N Engl J Med. 2000;342(5):314–319.
    4. Kwan P, et al. Epilepsia. 2010;51(6):1069–1077.